正常尿白蛋白水平在多种疾病预测中的研究进展

doi:10.12114/j.issn.1007-9572.2022.0240

中国全科医学 ›› 2022, Vol. 25 ›› Issue (33): 4191-4195.DOI: 10.12114/j.issn.1007-9572.2022.0240

正常尿白蛋白水平在多种疾病预测中的研究进展

孙珍珍¹^,², 刘欢欢³, 陈开宁³, 楼青青²^,^*()

1.210046　江苏省南京市，南京中医药大学护理学院
2.570102　海南省海口市，海南医学院第一附属医院
3.570311　海南省海口市，海南省人民医院内分泌科

收稿日期:2022-02-12 修回日期:2022-04-09 出版日期:2022-11-20 发布日期:2022-07-14
通讯作者: 楼青青
孙珍珍，刘欢欢，陈开宁，等.正常尿白蛋白水平在多种疾病预测中的研究进展[J].中国全科医学，2022，25（33）：4191-4195. [www.chinagp.net]
作者贡献：孙珍珍负责文章的构思与设计，文献、资料的收集，进行论文撰写；刘欢欢、陈开宁负责论文的修订，文章质量的控制及审校；楼青青负责文章的可行性分析，最终版本修订，对论文负责。
基金资助:
国家重点研发计划(2021YFE0204800); 海南省重点研发计划(ZDYF2021SHFZ236)

New Advances in the Value of the Normal Urinary Albumin as a Predictor of Multiple Diseases

SUN Zhenzhen¹^,², LIU Huanhuan³, CHEN Kaining³, LOU Qingqing²^,^*()

1.School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210046, China
2.The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China
3.Endocrinology Department, Hainan General Hospital, Haikou 570311, China

Received:2022-02-12 Revised:2022-04-09 Published:2022-11-20 Online:2022-07-14
Contact: LOU Qingqing
About author:
SUN Z Z, LIU H H, CHEN K N, et al. New advances in the value of the normal urinary albumin as a predictor of multiple diseases[J]. Chinese General Practice, 2022, 25 (33) : 4191-4195.

分享到

摘要/Abstract

摘要： 目前，关于正常尿白蛋白水平与相关疾病（包括糖尿病肾病、糖尿病视网膜病变、心血管疾病、代谢综合征等）之间的关系已被逐渐重视，越来越多的研究者也对正常尿白蛋白的范围提出了质疑。本文对正常尿白蛋白水平与不同疾病之间的关系及其可能的机制做一综述，旨在探讨正常尿白蛋白作为疾病预测因子的价值，并为今后正常尿白蛋白阈值的重新界定提供依据。

关键词: 白蛋白尿, 糖尿病肾病, 糖尿病视网膜病变, 心血管疾病, 代谢综合征, 综述

Abstract:

The association of the normal range of urinary albumin and its associated diseases (mainly including diabetic kidney diseases, diabetic retinopathy, cardiovascular disease, and metabolic syndrome) has been an increasing concern, and the range of normal urinary albumin has been questioned by a growing number of scholars. We reviewed the association of the normal range of urinary albumin with the aforementioned diseases and the possible mechanism of actions, to assess the value of normal-range urinary albumin as a predictor of the diseases, and to provide a basis for future redefinition of the threshold for the normal range of urine albumin.

Key words: Albuminuria, Diabetic kidney diseases, Diabetic retinopathy, Cardiovascular diseases, Metabolic syndrome, Review

孙珍珍,刘欢欢,陈开宁,等. 正常尿白蛋白水平在多种疾病预测中的研究进展[J]. 中国全科医学, 2022, 25(33): 4191-4195. DOI: 10.12114/j.issn.1007-9572.2022.0240.
SUN Zhenzhen,LIU Huanhuan,CHEN Kaining, et al. New Advances in the Value of the Normal Urinary Albumin as a Predictor of Multiple Diseases[J]. Chinese General Practice, 2022, 25(33): 4191-4195. DOI: 10.12114/j.issn.1007-9572.2022.0240.

参考文献 51

[1]	WARREN A M, KNUDSEN S T, COOPER M E. Diabetic nephropathy：an insight into molecular mechanisms and emerging therapies[J]. Expert Opin Ther Targets，2019，23(7):579-591. DOI：10.1080/14728222.2019.1624721.
[2]	RAJA P, MAXWELL A P, BRAZIL D P. The potential of albuminuria as a biomarker of diabetic complications[J]. Cardiovasc Drugs Ther，2021，35(3):455-466. DOI：10.1007/s10557-020-07035-4.
[3]	DEMBELE M, DELAFOSSE M, YOUSFI N，et al. Models of glomerular filtration barrier：new developments[J]. Med Sci（Paris），2021，37(3):242-248. DOI：10.1051/medsci/2021010.
[4]	YANG F, SHI J S, GONG S W，et al. An equation to estimate 24-hour total urine protein excretion rate in patients who underwent urine protein testing[J]. BMC Nephrol，2022，23(1):49. DOI：10.1186/s12882-022-02673-2.
[5]	AITEKENOV S, GAIPOV A, BUKASOV R. Review：detection and quantification of proteins in human urine[J]. Talanta，2021，223(Pt 1):121718. DOI：10.1016/j.talanta.2020.121718.
[6]	中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏病防治指南（2021年版）[J]. 中华糖尿病杂志，2021，13(8):762-784. DOI：10.3760/cma.j.cn115791-20210706-00369.
[7]	LIU R, ZHU H, YANG J H，et al. Can urine albumin/creatinine ratio replace 24 hours urinary albumin? [J]. Zhonghua Nei Ke Za Zhi，2019，58(5):377-381. DOI：10.3760/cma.j.issn.0578-1426.2019.05.009.
[8]	Kidney Disease：Improving Global Outcomes（KDIGO） Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease[J]. Kidney Int，2021，99(3S):S1-87. DOI：10.1016/j.kint.2020.11.003.
[9]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南（2020年版）[J]. 中华内分泌代谢杂志，2021，37(4):311-398. DOI：10.3760/cma.j.cn311282-20210304-00142.
[10]	KLIMONTOV V V, KORBUT A I. Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes[J]. Diabetes Metab Syndr，2019，13(1):474-479. DOI：10.1016/j.dsx.2018.11.014.
[11]	WANG H B, LOU Y J, MA Y J，et al. Estimating the glomerular filtration rate and tubular dysfunction in an elderly population with normoalbuminuria in China[J]. Clin Chim Acta，2019，495:377-381. DOI：10.1016/j.cca.2019.05.009.
[12]	KLIMONTOV V V, KORBUT A I. Normoalbuminuric chronic kidney disease in diabetes[J]. Ter Arkh，2018，90(10):94-98. DOI：10.26442/terarkh2018901094-98.
[13]	RETNAKARAN R, CULL C A, THORNE K I，et al. Risk factors for renal dysfunction in type 2 diabetes：U.K. Prospective Diabetes Study 74[J]. Diabetes，2006，55(6):1832-1839. DOI：10.2337/db05-1620.
[14]	CHIDA S, FUJITA Y, OGAWA A，et al. Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes：historical cohort study[J]. Sci Rep，2016，6:26380. DOI：10.1038/srep26380.
[15]	HAYASHI Y. Detection of lower albuminuria levels and early development of diabetic kidney disease using an artificial intelligence-based rule extraction approach[J]. Diagnostics （Basel），2019，9(4):E133. DOI：10.3390/diagnostics9040133.
[16]	LIN H T, ZHENG C M, WU Y C，et al. Diabetic retinopathy as a risk factor for chronic kidney disease progression：a multicenter case-control study in Taiwan[J]. Nutrients，2019，11(3):E509. DOI：10.3390/nu11030509.
[17]	GUI F, YOU Z P, FU S H，et al. Endothelial dysfunction in diabetic retinopathy[J]. Front Endocrinol （Lausanne），2020，11:591. DOI：10.3389/fendo.2020.00591.
[18]	DASH S, CHOUGULE A, MOHANTY S. Correlation of albuminuria and diabetic retinopathy in type-II diabetes mellitus patients[J]. Cureus，2022，14(2):e21927. DOI：10.7759/cureus.21927.
[19]	LEE M K, HAN K D, LEE J H，et al. Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes[J]. Sci Rep，2017，7(1):11757. DOI：10.1038/s41598-017-11906-6.
[20]	ROMERO-AROCA P, BAGET-BERNALDIZ M, NAVARRO-GIL R，et al. Glomerular filtration rate and/or ratio of urine albumin to creatinine as markers for diabetic retinopathy：a ten-year follow-up study[J]. J Diabetes Res，2018，2018:5637130. DOI：10.1155/2018/5637130.
[21]	HONG X Y, HUANG L N, ZHANG Y Z，et al. Stronger association of albuminuria with the risk of vascular complications than estimated glomerular filtration rate in type 2 diabetes[J]. Kidney Blood Press Res，2021，46(5):550-562. DOI：10.1159/000515163.
[22]	BENITEZ-AGUIRRE P Z, MARCOVECCHIO M L, CHIESA S T，et al. Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression：a natural history study from the Adolescent Cardio-Renal Intervention Trial（AdDIT） observational cohort[J]. Diabetologia，2022，65(5):872-878. DOI：10.1007/s00125-022-05661-1.
[23]	CHEN H B, ZHENG Z, HUANG Y，et al. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients[J]. PLoS One，2012，7(5):e36718. DOI：10.1371/journal.pone.0036718.
[24]	JOSEPH P, LEONG D, MCKEE M，et al. Reducing the global burden of cardiovascular disease，part 1：the epidemiology and risk factors[J]. Circ Res，2017，121(6):677-694. DOI：10.1161/CIRCRESAHA.117.308903.
[25]	WAHAB M A K A, SAAD M M, BARAKA K A G. Microalbuminuria is a late event in patients with hypertension：do we need a lower threshold? [J]. J Saudi Heart Assoc，2017，29(1):30-36. DOI：10.1016/j.jsha.2015.12.003.
[26]	ZHANG M Z, JIANG Y B, ZHANG Q，et al. Bidirectional and temporal association between hypertension and microalbuminuria：a longitudinal study in Chinese adults[J]. J Am Heart Assoc，2018，7(22):e010723. DOI：10.1161/JAHA.118.010723.
[27]	FUNG C S, WAN E Y, CHAN A K，et al. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study[J]. BMC Nephrol，2017，18(1):47. DOI：10.1186/s12882-017-0468-y.
[28]	PAFUNDI P C, GAROFALO C, GALIERO R，et al. Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects[J]. Diagnostics（Basel），2021，11(2):290. DOI：10.3390/diagnostics11020290.
[29]	MÁRQUEZ D F, RUIZ-HURTADO G, SEGURA J，et al. Microalbuminuria and cardiorenal risk：old and new evidence in different populations[J]. F1000Res，2019，8:F1000 Faculty Rev-F1000 Faculty 1659. DOI：10.12688/f1000research.17212.1.
[30]	WEINER D E, PARK M, TIGHIOUART H，et al. Albuminuria and allograft failure，cardiovascular disease events，and all-cause death in stable kidney transplant recipients：a cohort analysis of the FAVORIT trial[J]. Am J Kidney Dis，2019，73(1):51-61. DOI：10.1053/j.ajkd.2018.05.015.
[31]	LI B, CHEN K, WANG J，et al. Low-grade albuminuria is associated with high cardiovascular risk in CVD-free and normoalbuminuric Chinese adults：results from the REACTION study[J]. J Diabetes，2021，13(8):648-660. DOI：10.1111/1753-0407.13152.
[32]	KAKUTANI Y, MORIOKA T, MORI K，et al. Albuminuria rather than glomerular filtration rate is associated with vascular endothelial function in patients with type 2 diabetes[J]. J Diabetes Complications，2020，34(12):107702. DOI：10.1016/j.jdiacomp.2020.107702.
[33]	KELLY D, ROTHWELL P M. Disentangling the multiple links between renal dysfunction and cerebrovascular disease[J]. J Neurol Neurosurg Psychiatry，2020，91(1):88-97. DOI：10.1136/jnnp-2019-320526.
[34]	ARNLÖV J, EVANS J C, MEIGS J B，et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals：the Framingham Heart Study[J]. Circulation，2005，112(7):969-975. DOI：10.1161/CIRCULATIONAHA.105.538132.
[35]	Chronic Kidney Disease Prognosis Consortium, MATSUSHITA K, VAN DER VELDE M，et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts：a collaborative Meta-analysis[J]. Lancet，2010，375(9731):2073-2081. DOI：10.1016/S0140-6736(10)60674-5.
[36]	ECKEL R H, JAKICIC J M, ARD J D，et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk：a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol，2014，63(25 Pt B):2960-2984. DOI：10.1016/j.jacc.2013.11.003.
[37]	EASTWOOD S V, CHATURVEDI N, SATTAR N，et al. Impact of kidney function on cardiovascular risk and mortality：a comparison of south Asian and European cohorts[J]. Am J Nephrol，2019，50(6):425-433. DOI：10.1159/000503873.
[38]	LIU S S, NIU J Y, WU S J，et al. Urinary albumin-to-creatinine ratio levels are associated with subclinical atherosclerosis and predict CVD events and all-cause deaths：a prospective analysis[J]. BMJ Open，2021，11(3):e040890. DOI：10.1136/bmjopen-2020-040890.
[39]	XIE X K, PENG Z L, LI H L，et al. Association of urine albumin/creatinine ratio below 30 mg/g and left ventricular hypertrophy in patients with type 2 diabetes[J]. Biomed Res Int，2020，2020:5240153. DOI：10.1155/2020/5240153.
[40]	CARBALLO-CASLA A, GARCÍA-ESQUINAS E, BUÑO-SOTO A，et al. Metabolic syndrome and growth differentiation factor 15 in older adults[J]. Geroscience，2021. DOI：10.1007/s11357-021-00370-w.
[41]	VYSSOULIS G, KARPANOU E, SPANOS P，et al. Urine albumin excretion，within normal range，reflects increasing prevalence of metabolic syndrome in patients with essential hypertension[J]. J Clin Hypertens （Greenwich），2010，12(8):597-602. DOI：10.1111/j.1751-7176.2010.00306.x.
[42]	GE Z, GUO X L, CHEN X R，et al. Are microalbuminuria and elevated 24 h urinary microalbumin excretion within normal range associated with metabolic syndrome in Chinese adults? [J]. PLoS One，2015，10(9):e0138410. DOI：10.1371/journal.pone.0138410.
[43]	ZHANG J, CHEN Y H, XU Y，et al. Low-grade albuminuria is associated with metabolic syndrome and its components in middle-aged and elderly Chinese population[J]. PLoS One，2013，8(6):e65597. DOI：10.1371/journal.pone.0065597.
[44]	REN M, YOU L L, LIN D Z，et al. Association of metabolic syndrome with the incidence of low-grade albuminuria：a cohort study in middle-aged and elderly Chinese adults[J]. Aging（Albany NY），2021，13(5):7350-7360. DOI：10.18632/aging.202592.
[45]	PARK S Y, PARK Y K, CHO K H，et al. Normal range albuminuria and metabolic syndrome in South Korea：the 2011-2012 Korean National Health and Nutrition Examination Survey[J]. PLoS One，2015，10(5):e0125615. DOI：10.1371/journal.pone.0125615.
[46]	OH C M, PARK S K, KIM H S，et al. High-normal albuminuria predicts metabolic syndrome in middle-aged Korean men：a prospective cohort study[J]. Maturitas，2014，77(2):149-154. DOI：10.1016/j.maturitas.2013.10.013.
[47]	KABASAWA K, HOSOJIMA M, ITO Y，et al. Association of metabolic syndrome traits with urinary biomarkers in Japanese adults[J]. Diabetol Metab Syndr，2022，14(1):9. DOI：10.1186/s13098-021-00779-5.
[48]	SCHUTTE R, SCHUTTE A E, HUISMAN H W，et al. Arterial stiffness，ambulatory blood pressure and low-grade albuminuria in non-diabetic African and Caucasian men：the SABPA study[J]. Hypertens Res，2011，34(7):862-868. DOI：10.1038/hr.2011.45.
[49]	NICHOLL D D, HEMMELGARN B R, TURIN T C，et al. Increased urinary protein excretion in the "normal" range is associated with increased renin-angiotensin system activity[J]. Am J Physiol Renal Physiol，2012，302(5):F526-532. DOI：10.1152/ajprenal.00458.2011.
[50]	PEREIRA-MOREIRA R, MUSCELLI E. Effect of insulin on proximal tubules handling of glucose：a systematic review[J]. J Diabetes Res，2020，2020:8492467. DOI：10.1155/2020/8492467.
[51]	SAKHAEI F, KESHVARI M, ASGARY S，et al. Enzymatic antioxidant system and endothelial function in patients with metabolic syndrome[J]. ARYA Atheroscler，2020，16(2):94-101. DOI：10.22122/arya.v16i2.1813.

正常尿白蛋白水平在多种疾病预测中的研究进展

New Advances in the Value of the Normal Urinary Albumin as a Predictor of Multiple Diseases

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 51

相关文章 15

编辑推荐

Metrics

留言

[1]	王旭, 魏戌, 朱立国, 冯天笑, 王志鹏, 师彬. 医工结合的中医手法治疗脊柱退行性疾病疗效机制研究：思路与前景[J]. 中国全科医学, 2023, 26(33): 4118-4124.
[2]	辛功恺, 丛欣, 袁磊, 程悦彤, 倪翠萍, 张巍巍, 張平平, 刘宇. 失智症老年人综合评估工具的研究进展[J]. 中国全科医学, 2023, 26(33): 4103-4109.
[3]	张思宇, 周郁秋, 杜晓慧, 王正君. 精神病未治期及其早期干预的研究进展[J]. 中国全科医学, 2023, 26(33): 4110-4117.
[4]	孟江涛, 杨思宇, 孙蕾, 雷瑞宁, 赵晓霞. 弥散张量成像联合运动诱发电位评估脑梗死偏瘫患者运动功能预后价值的研究进展[J]. 中国全科医学, 2023, 26(32): 4098-4102.
[5]	马丽媛, 王增武, 樊静, 胡盛寿. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国全科医学, 2023, 26(32): 3975-3994.
[6]	王佳欣, 赵亚利. 国内外医疗团队合作评估工具系统综述[J]. 中国全科医学, 2023, 26(31): 3951-3962.
[7]	卫梦雨, 王佳佳, 张莹莹, 李春阳, 李建生. 阻塞性睡眠呼吸暂停患者报告结局测评工具研究现状分析[J]. 中国全科医学, 2023, 26(30): 3725-3733.
[8]	苑喜微, 南月敏. 线粒体融合蛋白2的结构和功能及其在肝脏疾病中作用机制的研究进展[J]. 中国全科医学, 2023, 26(30): 3841-3846.
[9]	肖雨倩, 白艳杰, 王岩, 陈淑颖, 陈丽敏, 孙可心, 万俊. 线粒体转移在脑卒中后认知障碍中的研究进展[J]. 中国全科医学, 2023, 26(30): 3833-3840.
[10]	刘煜, 岳婷, 杨东宇, 赵中亭, 杨吉勃, 朱田田. 自噬在类风湿关节炎发病机制中的研究进展[J]. 中国全科医学, 2023, 26(29): 3710-3714.
[11]	周小琦, 刘新会, 张微, 李长风, 严亚琼. 老年人丙氨酸氨基转移酶和天冬氨酸氨基转移酶/丙氨酸氨基转移酶与2型糖尿病及代谢综合征的相关性研究[J]. 中国全科医学, 2023, 26(29): 3645-3649.
[12]	潘姚佳, 王为强, 易伟卓, 高兵, 傅方琳, 韩正, 孙梦, 董雅勤, 顾怀聪. 不同性别中年肥胖居民三酰甘油葡萄糖乘积指数与心血管疾病高危风险的关系研究[J]. 中国全科医学, 2023, 26(29): 3628-3635.
[13]	蒲瑜, 张吉翔, 董卫国. 铁死亡与炎症性肠病的研究进展[J]. 中国全科医学, 2023, 26(29): 3698-3703.
[14]	任延峰, 刘世蒙, 陶颖, 陈英耀. 抑郁症患者药物治疗偏好的系统综述：基于离散选择实验和优劣尺度法[J]. 中国全科医学, 2023, 26(28): 3559-3564.
[15]	陈晓芬, 陈钰涵, 马娟. 炎症性肠病新型治疗方法的研究进展[J]. 中国全科医学, 2023, 26(27): 3349-3354.